Sage Therapeutics to Present at the Stifel 2019 Healthcare Conference
Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019, at 10:20 a.m. EST in New York, NY.
A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage's website following the conference.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.
Ghost Security, a leading provider of modern application and API security solutions, is proud to announce the early access availability of Phantasm, application-specific threat intelligence poised to fill a large gap that currently exists in both...
Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system...
RSA Conference ? The Cloud Security Alliance (CSA), the world's leading organization dedicated to defining standards, certifications, and best practices to help ensure a secure cloud computing environment, has issued a new report, Confronting Shadow...
Mark43, the leading cloud-native public safety software provider today announced that it has earned the Federal Risk and Authorization Management Program (FedRAMP®) High Authorization through agency sponsorship by the United States Secret Service...
Securonix, Inc., a market leader in AI-Reinforced CyberOps, today announced a collaboration with Amazon Web Services (AWS) to use Amazon Bedrock, a fully managed service that offers a choice of high-performing foundation models (FMs) from leading...
